Johnson & Johnson said it received overwhelming support for a roughly $8 billion settlement of claims that its talc-based baby powder caused cancer, a key step as the company makes its third attempt to resolve thousands of lawsuits in bankruptcy court.

Pointing out that "most ovarian claimants have not recovered and will not recover anything at trial," the company says the roughly $8 billion deal offers a much better alternative to petitioners.